670 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
Achieve Life Sciences falls as FDA seeks more data on lead product https://seekingalpha.com/news/4045696-achieve-life-sciences-stock-falls-fda-seeks-more-data?source=feed_sector_healthcare Dec 12, 2023 - Achieve Life Sciences (ACHV) dropped 43% as the US FDA sought more data to support a marketing application for its smoking cessation product. Read more here.
U.S. Stocks Move Modestly Higher Following Inflation Data https://www.rttnews.com/story.aspx?Id=3411074 Dec 12, 2023 - After initially showing a lack of direction, stocks have moved modestly higher over the course of the trading session on Tuesday. The major averages have inched up to their best intraday levels in well over a year. The major averages have seen further upside in recent trading, reaching new highs for the session.
Inflation Data May Contribute To Extended Upward Move On Wall Street https://www.rttnews.com/story.aspx?Id=3411059 Dec 12, 2023 - The major U.S. index futures are currently pointing to a modestly higher open on Tuesday, with stocks likely to extend the upward move seen over the past few sessions.
3 Sector ETFs & Stocks to Bet on November Jobs Data https://www.zacks.com/stock/news/2196615/3-sector-etfs-stocks-to-bet-on-november-jobs-data?cid=CS-ZC-FT-etf_news_and_commentary-2196615 Dec 12, 2023 - The November U.S. jobs report showed continued resilience in the labor market. U.S. non-farm payrolls grew by 199,000 last month, the Labor Department said Friday. That was more than the 190,000 jobs anticipated by economists surveyed by Dow Jones.
Wall Street Seen Opening Slightly Higher; Inflation Data In Focus https://www.rttnews.com/story.aspx?Id=3411013 Dec 12, 2023 - Futures suggest a slightly positive start for U.S. stocks Tuesday morning, but it will be the data on consumer price inflation that will determine the mood. With the Federal Reserve's monetary policy decision due on Wednesday, the mood in the market is likely to remain somewhat cautious.
European Economic News Preview: UK Unemployment Data Due https://www.rttnews.com/3410860/european-economic-news-preview-uk-unemployment-data-due.aspx?type=alleco Dec 11, 2023 - Unemployment from the UK and economic sentiment from Germany are the major economic reports due on Tuesday, headlining a light day for the European economic news. At 2.00 am ET, the Office for National Statistics releases UK unemployment data for October. The jobless rate is forecast to remain unchanged at 4.2 percent in three months to October.
Editas Medicine, Inc. (EDIT) EDIT-301 Program Update: RUBY and EdiTHAL Trials Data Update (Transcript) https://seekingalpha.com/article/4657329-editas-medicine-inc-edit-editminus-301-program-update-ruby-and-edithal-trials-data-update?source=feed_sector_transcripts Dec 11, 2023 - Editas Medicine, Inc. (NASDAQ:NASDAQ:EDIT) EDIT-301 Program Update: RUBY and EdiTHAL Trials Data Update December 11, 2023 1:00 PM ETCompany...
Japan Producer Price Data Due On Tuesday https://www.rttnews.com/3410549/japan-producer-price-data-due-on-tuesday.aspx?type=alleco Dec 11, 2023 - Japan will on Tuesday release November numbers for producer prices, highlighting a light day for Asia-Pacific economic activity.
MorphoSys climbs after late-stage data for blood cancer therapy https://seekingalpha.com/news/4045175-morphosys-stock-climbs-data-blood-cancer-therapy?source=feed_sector_healthcare Dec 11, 2023 - MorphoSys (MOR) shares surge 22% as Phase 3 results show promising outcomes for pelabresib in treating a rare bone marrow cancer called myelofibrosis. Read more here.
Keros falls after mid-stage data for blood cancer therapy https://seekingalpha.com/news/4045165-keros-stock-falls-after-mid-stage-data-blood-cancer-drug?source=feed_sector_healthcare Dec 11, 2023 - Keros Therapeutics (KROS) stocks fell 16% after updating data from two Phase 2 trials for its lead protein drug in rare forms of blood cancer. Read more here.

Pages: 1...5556575859606162636465...67

<<<Page 60>